Cell Culture Technology– category –
-
HTMP Biotechnology Unveils HTMP™ 192 High-Throughput Platform for 3D Cell Culture, Revolutionizing Drug Discovery and Disease Modeling
HTMP Biotechnology USA Overview HTMP Biotechnology has launched its "HTMP™ 192" high-throughput microwell platform, designed to enable stable 3D cell culture workflows, addressing the critical challenge of disturbing 3D cellular structur... -
Matica Biotechnology and Cirsium Biosciences Partner to Accelerate Flexible AAV Manufacturing via Matica Open Access Platform, Integrating Plant-Based Technology and Single-Use Innovations
BioSpace USA Overview Matica Biotechnology and Cirsium Biosciences announced the adoption of Matica's Open Access Platform to enhance flexibility, transparency, and scalability in Adeno-Associated Virus (AAV) development and manufacturin... -
Matica Biotechnology Launches Integrated Korea IIT Platform: Linking US Manufacturing with Korean Clinical Execution to Accelerate Advanced Therapy Development
PR Newswire (Matica Biotechnology) USA, South Korea Overview Matica Biotechnology has launched the 'Accelerated Matica Korea IIT Integrated Platform Solution,' designed to efficiently link U.S. manufacturing with clinical execution in So... -
ACS Publications Reviews Metabolomics-Guided Metabolite Production in Plant Tissue Culture: Integrating Omics and Synthetic Biology for Enhanced Yields
ACS Publications USA Overview A comprehensive review in ACS Publications focuses on metabolomics-guided metabolite production in plant tissue culture (PTC), aiming to enhance yields by integrating omics and synthetic biology. Key solutio... -
ASCO 2026 Highlights CAR-T Cell Therapy Evolution in Multiple Myeloma: Focus on Rapid Manufacturing, Dual-Targeting, and Lentiviral Approaches
YouTube (OncUpdates) USA Overview A YouTube video featuring Dr. Hamza Hashmi discussed the latest advancements in CAR-T therapy for multiple myeloma at ASCO 2026. CAR-T therapy has evolved from a last-resort treatment to a viable option ... -
CDMO Signal Ranks Lentiviral Vector (LVV) CDMOs: GMP Standards and Robust Assays Key for Selection
CDMO Signal USA Overview CDMO Signal published its ranking of Lentiviral Vector (LVV) CDMOs based on Signal Score. LVVs are critical in ex vivo gene therapies for engineering CAR-T cells and modifying hematopoietic stem cells, necessitat... -
PMC Reports Multi-Component 3D Bioprinted Platform with Sacrificial Matrix and Collagen-Based Bioinks Developed for Skeletal Muscle Tissue Engineering
PMC (Published in Pharmaceutics) USA Overview A study published in PMC (Pharmaceutics) describes a multi-component 3D bioprinted platform for skeletal muscle tissue engineering. This system integrates a PCL support for mechanical stabili... -
Frontiers Reports VR-Based Bioreactor Developed for Biomanufacturing and Environmental Engineering Labs: Enhancing Student Education and Access to High-Cost Equipment
Frontiers in Education Switzerland Overview A study published in Frontiers in Education describes the development of a virtual reality (VR)-based bioreactor for biomanufacturing and environmental engineering labs. Modeled after a detaile... -
Qihan Biotech Receives FDA RMAT and Breakthrough Therapy Designations for Universal Dual-Target CAR-T Therapy, Supported by PackGene Biotech’s CDMO Expertise
PackGene Biotech China Overview Qihan Biotech announced that its universal dual-target CAR-T therapy received both Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy designations from the U.S. FDA. PackGene Biotech, a... -
Lonza Presents Optimization Strategies to Address Purity and Potency Challenges in In Vivo Lentiviral Vector Development for Cell and Gene Therapies
Biocompare Switzerland Overview Lonza outlined optimization strategies for lentiviral vector (LVV) development for in vivo delivery of cell and gene therapies. Key challenges in LVV development include achieving purity, complexity of val...
